
Johnson Fistel Announces Investigation Into Acadia Healthcare Company, Inc.
What if I purchased Acadia Healthcare common stock? If you purchased securities in the company and suffered losses on your investment, join our investigation now:
Or for more information, contact Jim Baker at ... or (619) 814-4471
There is no cost or obligation to you.
What is Johnson Fistel investigating? Acadia Healthcare, on September 26, 2024, consented to a settlement of $19.85 million to address allegations asserting that the company submitted claims for medically unnecessary inpatient behavioral health services, the U.S. Justice Department announced. Of this settlement, $16.66 million will be disbursed to the U.S. government to resolve accusations of fraudulent billing under federal health programs, and an additional $3.19 million will be allocated to the states of Florida, Georgia, Michigan, and Nevada to settle claims under respective state laws.
About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York, Georgia, and Colorado. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit .
Attorney advertising.
Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices.
Johnson Fistel, LLP has paid for the dissemination of this promotional communication, and Frank J. Johnson is the attorney responsible for its content.
Contact:
Johnson Fistel, LLP
501 W. Broadway, Suite 800, San Diego, CA 92101
James Baker, Investor Relations or Frank J. Johnson, Esq., (619) 814-4471
... or ...


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.
Comments
No comment